PALOPEGTERIPARATIDE

PALOPEGTERIPARATIDE was reported 0 times

PALOPEGTERIPARATIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTRACRANIAL CALCIFICATION 2 0.0541
1 HYPOCALCAEMIC SEIZURE 1 0.0133
2 DECOMPENSATED HYPOTHYROIDISM 1 0.0074
3 URINE CALCIUM INCREASED 2 0.0063
4 HYPERCALCIURIA 3 0.0061
5 RICKETS 1 0.0053
6 PRODUCT CONTAMINATION WITH BODY FLUID 1 0.0049
7 POST PROCEDURAL HYPOTHYROIDISM 1 0.0047
8 EXTRASKELETAL OSSIFICATION 1 0.0047
9 HYPOCALCAEMIA 85 0.0045
10 BLOOD CALCIUM ABNORMAL 7 0.0042
11 HYPERCALCAEMIA 51 0.0041
12 HYPERCALCAEMIA OF MALIGNANCY 1 0.0037
13 INTENTIONAL DEVICE USE ISSUE 3 0.0035
14 TETANY 6 0.0033
15 GASTROENTERITIS ROTAVIRUS 1 0.0032
16 TACHYPHYLAXIS 1 0.0029
17 BLOOD CALCIUM DECREASED 28 0.0025
18 INVASIVE BREAST CARCINOMA 1 0.0024
19 MULTIPLE ACYL-COENZYME A DEHYDROGENASE DEFICIENCY 1 0.0023
20 SOFT TISSUE MASS 1 0.0022
21 MORNING SICKNESS 1 0.0018
22 RECALLED PRODUCT 3 0.0017
23 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
24 SACRAL PAIN 1 0.0016
25 FRACTURED SACRUM 2 0.0016
26 BLOOD CALCIUM INCREASED 14 0.0016
27 THIRST DECREASED 1 0.0016
28 FACIAL DISCOMFORT 1 0.0014
29 GRANULOMA ANNULARE 1 0.0014
30 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0013
31 PRODUCT KNOWLEDGE DEFICIT 1 0.0013
32 LIP ERYTHEMA 1 0.0013
33 NON-SMALL CELL LUNG CANCER METASTATIC 1 0.0011
34 BLOOD UREA ABNORMAL 1 0.0011
35 THYROID HORMONES INCREASED 1 0.0010
36 KETOSIS 1 0.0009
37 NEPHROCALCINOSIS 1 0.0008
38 CALCIUM DEFICIENCY 1 0.0008
39 BILIARY OBSTRUCTION 1 0.0008
40 BODY MASS INDEX INCREASED 1 0.0007
41 BLOOD PHOSPHORUS INCREASED 2 0.0007
42 CORNEAL ABRASION 1 0.0007
43 BLOOD ELECTROLYTES DECREASED 1 0.0007
44 VITAMIN D DECREASED 6 0.0007
45 BRAIN FOG 11 0.0007
46 HAEMORRHAGE IN PREGNANCY 1 0.0007
47 PELVIC VENOUS THROMBOSIS 1 0.0007
48 CHOLANGIOCARCINOMA 1 0.0007
49 ANTIBODY TEST POSITIVE 1 0.0006
50 INJECTION SITE REACTION 40 0.0006
51 BURNS SECOND DEGREE 1 0.0006
52 COMPRESSION FRACTURE 3 0.0006
53 BLOOD PHOSPHORUS DECREASED 2 0.0005
54 ESSENTIAL HYPERTENSION 1 0.0005
55 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
56 TUNNEL VISION 1 0.0005
57 HYPOGLYCAEMIC UNCONSCIOUSNESS 1 0.0005
58 PHOTOPSIA 3 0.0005
59 SPINAL COLUMN INJURY 1 0.0004
60 LUMBAR VERTEBRAL FRACTURE 2 0.0004
61 URINARY TRACT OBSTRUCTION 1 0.0004
62 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 19 0.0004
63 HYPOPHOSPHATAEMIA 3 0.0004
64 URINE OUTPUT INCREASED 1 0.0004
65 INJECTION SITE DISCHARGE 2 0.0004
66 JOINT LOCK 1 0.0004
67 PRODUCT AVAILABILITY ISSUE 8 0.0004
68 MASTICATION DISORDER 1 0.0003
69 BLEPHAROSPASM 2 0.0003
70 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
71 SUSPECTED COVID-19 1 0.0003
72 NEPHRITIS 1 0.0003
73 THROMBOPHLEBITIS 1 0.0003
74 FIBRIN D DIMER INCREASED 1 0.0003
75 SKIN WEEPING 1 0.0003
76 PARAESTHESIA ORAL 4 0.0003
77 HYPOAESTHESIA ORAL 4 0.0003
78 PRODUCT STORAGE ISSUE 1 0.0003
79 MUSCLE TWITCHING 6 0.0003
80 INJECTION SITE URTICARIA 6 0.0002
81 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
82 HEPATIC PAIN 1 0.0002
83 CHAPPED LIPS 1 0.0002
84 IRON DEFICIENCY 1 0.0002
85 APPENDICITIS 2 0.0002
86 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
87 KIDNEY TRANSPLANT REJECTION 1 0.0002
88 HYPERTHYROIDISM 3 0.0002
89 NEEDLE ISSUE 6 0.0002
90 HORMONE LEVEL ABNORMAL 1 0.0002
91 DEVICE USE ERROR 7 0.0002
92 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
93 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
94 STRESS FRACTURE 1 0.0002
95 PHARYNGITIS STREPTOCOCCAL 2 0.0002
96 ORTHOSTATIC HYPOTENSION 3 0.0002
97 HYPOVOLAEMIA 1 0.0002
98 ENERGY INCREASED 1 0.0002
99 SYMPTOM RECURRENCE 1 0.0002
100 BLOOD POTASSIUM DECREASED 5 0.0002
101 SCOLIOSIS 1 0.0002
102 OLIGURIA 1 0.0002
103 SWELLING OF EYELID 1 0.0002
104 WALKING AID USER 1 0.0002
105 SPINAL FRACTURE 3 0.0001
106 POSTOPERATIVE WOUND INFECTION 1 0.0001
107 TASTE DISORDER 3 0.0001
108 ABNORMAL LOSS OF WEIGHT 1 0.0001
109 HYPOMAGNESAEMIA 2 0.0001
110 EXTRASYSTOLES 1 0.0001
111 INTENTIONAL DOSE OMISSION 4 0.0001
112 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
113 PARAESTHESIA 21 0.0001
114 OSTEOPENIA 2 0.0001
115 TRANSPLANT REJECTION 1 0.0001
116 POLYURIA 1 0.0001
117 HYPERAESTHESIA 1 0.0001
118 BONE PAIN 7 0.0001
119 PERICARDITIS 2 0.0001
120 BLOOD MAGNESIUM DECREASED 1 0.0001
121 DEVICE DEFECTIVE 2 0.0001
122 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
123 HEAD DISCOMFORT 2 0.0001
124 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
125 THERAPY INTERRUPTED 8 0.0001
126 THIRST 2 0.0001
127 LIMB INJURY 3 0.0001
128 NEPHROLITHIASIS 5 0.0001
129 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
130 UROSEPSIS 1 0.0001
131 NERVE COMPRESSION 1 0.0001
132 PRESCRIBED OVERDOSE 2 0.0001
133 DIZZINESS POSTURAL 1 0.0001
134 ORAL HERPES 2 0.0001
135 PHARYNGEAL SWELLING 1 0.0001
136 VITREOUS FLOATERS 1 0.0001
137 HYPOTONIA 1 0.0001
138 BRAIN INJURY 1 0.0001
139 INJURY ASSOCIATED WITH DEVICE 2 0.0001
140 POLLAKIURIA 4 0.0001
141 PRODUCT ODOUR ABNORMAL 1 0.0001
142 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
143 HEAD INJURY 3 0.0001
144 NIGHT SWEATS 3 0.0001
145 SKIN LACERATION 1 0.0001
146 OESOPHAGITIS 1 0.0001
147 BLOOD GLUCOSE FLUCTUATION 1 0.0001
148 VIRAL INFECTION 3 0.0001
149 HYPERTENSIVE CRISIS 1 0.0001
150 NEPHROPATHY TOXIC 1 0.0001
151 MICTURITION URGENCY 1 0.0001
152 NEOPLASM 1 0.0001
153 HYPOAESTHESIA 13 0.0001
154 SPINAL PAIN 1 0.0001
155 HYPERLIPIDAEMIA 1 0.0001
156 THYROID CANCER 1 0.0001
157 ADRENAL INSUFFICIENCY 1 0.0001
158 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
159 HAIR COLOUR CHANGES 1 0.0001
160 DEVICE DIFFICULT TO USE 5 0.0001
161 ABORTION SPONTANEOUS 3 0.0001
162 HEPATIC ENZYME INCREASED 5 0.0001
163 DEVICE MECHANICAL ISSUE 1 0.0001
164 HUNGER 1 0.0001
165 COORDINATION ABNORMAL 1 0.0001
166 MASS 1 0.0001
167 SKIN REACTION 1 0.0001
168 SEASONAL ALLERGY 1 0.0001
169 BRONCHOSPASM 1 0.0001
170 SUBDURAL HAEMATOMA 1 0.0001
171 ANGINA PECTORIS 2 0.0001
172 PALPITATIONS 8 0.0001
173 LABORATORY TEST ABNORMAL 2 0.0001
174 GASTROINTESTINAL DISORDER 6 0.0001
175 MUSCLE SPASMS 12 0.0001
176 HYPOKALAEMIA 3 0.0001
177 EXPOSURE DURING PREGNANCY 4 0.0001
178 SENSORY DISTURBANCE 1 0.0001
179 BLOOD POTASSIUM INCREASED 1 0.0001
180 SEIZURE 7 0.0001
181 MUSCULOSKELETAL DISCOMFORT 1 0.0001
182 PRODUCT DOSE OMISSION ISSUE 17 0.0001
183 DEVICE USE ISSUE 1 0.0001
184 GALLBLADDER DISORDER 1 0.0001
185 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
186 RASH PRURITIC 3 0.0001
187 TOOTHACHE 1 0.0001
188 RESTLESS LEGS SYNDROME 1 0.0001
189 ANAPHYLACTIC REACTION 3 0.0001
190 MIDDLE INSOMNIA 1 0.0001
191 DYSPNOEA EXERTIONAL 2 0.0001
192 FRACTURE 1 0.0001
193 FEELING JITTERY 1 0.0001
194 LETHARGY 3 0.0001
195 SEROTONIN SYNDROME 1 0.0001
196 ACUTE RESPIRATORY FAILURE 1 0.0001
197 ERUCTATION 1 0.0001
198 BACK PAIN 12 0.0001
199 KIDNEY INFECTION 1 0.0001
200 BLOOD PRESSURE ABNORMAL 1 0.0001
201 PRESCRIBED UNDERDOSE 1 0.0001
202 SYNCOPE 5 0.0000
203 DRY MOUTH 4 0.0000
204 PRODUCT PREPARATION ERROR 1 0.0000
205 OSTEOPOROSIS 2 0.0000
206 TOOTH LOSS 1 0.0000
207 RENAL IMPAIRMENT 4 0.0000
208 MOUTH ULCERATION 1 0.0000
209 LIVER FUNCTION TEST INCREASED 1 0.0000
210 DIZZINESS 23 0.0000
211 SWELLING FACE 3 0.0000
212 PRODUCT DISPENSING ERROR 1 0.0000
213 TRANSAMINASES INCREASED 1 0.0000
214 TINNITUS 2 0.0000
215 HEADACHE 27 0.0000
216 COMA 2 0.0000
217 MIGRAINE 4 0.0000
218 URTICARIA 7 0.0000
219 NEURALGIA 1 0.0000
220 INCORRECT DOSE ADMINISTERED 9 0.0000
221 CARDIOVASCULAR DISORDER 1 0.0000
222 NAUSEA 31 0.0000
223 LOSS OF CONSCIOUSNESS 5 0.0000
224 ANAPHYLACTIC SHOCK 1 0.0000
225 SKIN ULCER 1 0.0000
226 SPEECH DISORDER 2 0.0000
227 GASTRITIS 1 0.0000
228 CARDIAC FAILURE 3 0.0000
229 THROAT TIGHTNESS 1 0.0000
230 TREATMENT NONCOMPLIANCE 2 0.0000
231 DIVERTICULITIS 1 0.0000
232 MENTAL STATUS CHANGES 1 0.0000
233 HAEMOPTYSIS 1 0.0000
234 EYE PAIN 2 0.0000
235 PAIN IN JAW 1 0.0000
236 DECREASED APPETITE 8 0.0000
237 DYSSTASIA 1 0.0000
238 PAIN IN EXTREMITY 10 0.0000
239 ACUTE MYOCARDIAL INFARCTION 1 0.0000
240 CATARACT 2 0.0000
241 DEVICE ISSUE 3 0.0000
242 APHASIA 1 0.0000
243 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
244 DISCOMFORT 2 0.0000
245 INJECTION SITE ERYTHEMA 4 0.0000
246 SWOLLEN TONGUE 1 0.0000
247 BONE DENSITY DECREASED 1 0.0000
248 ASTHENIA 12 0.0000
249 VOMITING 15 0.0000
250 DRUG-INDUCED LIVER INJURY 1 0.0000
251 GAIT DISTURBANCE 6 0.0000
252 ARTHRALGIA 13 0.0000
253 HIP FRACTURE 1 0.0000
254 OSTEONECROSIS 1 0.0000
255 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
256 URINARY RETENTION 1 0.0000
257 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
258 MYALGIA 5 0.0000
259 SINUSITIS 3 0.0000
260 NEOPLASM PROGRESSION 1 0.0000
261 BURNING SENSATION 2 0.0000
262 FATIGUE 22 0.0000
263 MOBILITY DECREASED 2 0.0000
264 PANIC ATTACK 1 0.0000
265 NASOPHARYNGITIS 5 0.0000
266 INFLUENZA 3 0.0000
267 DYSARTHRIA 1 0.0000
268 MUSCULAR WEAKNESS 3 0.0000
269 PLASMA CELL MYELOMA 1 0.0000
270 THROMBOSIS 2 0.0000
271 EXTRA DOSE ADMINISTERED 1 0.0000
272 DEVICE BREAKAGE 1 0.0000
273 FALL 8 0.0000
274 SKIN EXFOLIATION 2 0.0000
275 HYPERTENSION 5 0.0000
276 OSTEOARTHRITIS 1 0.0000
277 URINARY TRACT INFECTION 4 0.0000
278 HYPOACUSIS 1 0.0000
279 BALANCE DISORDER 2 0.0000
280 DEVICE LEAKAGE 1 0.0000
281 MENTAL DISORDER 1 0.0000
282 RENAL FAILURE 3 0.0000
283 LIVER DISORDER 1 0.0000
284 TACHYCARDIA 2 0.0000
285 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
286 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
287 SKIN DISCOLOURATION 1 0.0000
288 DIARRHOEA 14 0.0000
289 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
290 WEIGHT DECREASED 6 0.0000
291 COGNITIVE DISORDER 1 0.0000
292 ARRHYTHMIA 1 0.0000
293 DYSPHAGIA 2 0.0000
294 PULMONARY EMBOLISM 2 0.0000
295 PRODUCTIVE COUGH 1 0.0000
296 FEELING ABNORMAL 5 0.0000
297 BLOOD GLUCOSE DECREASED 1 0.0000
298 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
299 PRURITUS 8 0.0000
300 HYPOGLYCAEMIA 1 0.0000
301 ATRIAL FIBRILLATION 2 0.0000
302 MALAISE 9 0.0000
303 BLOOD PRESSURE INCREASED 3 0.0000
304 ACUTE KIDNEY INJURY 3 0.0000
305 CHEST DISCOMFORT 2 0.0000
306 ECZEMA 1 0.0000
307 MUSCULOSKELETAL PAIN 1 0.0000
308 CONFUSIONAL STATE 3 0.0000
309 TREMOR 3 0.0000
310 ARTHROPATHY 1 0.0000
311 OXYGEN SATURATION DECREASED 1 0.0000
312 ASTHMA 2 0.0000
313 ANXIETY 5 0.0000
314 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
315 IRRITABILITY 1 0.0000
316 THERAPEUTIC RESPONSE DECREASED 1 0.0000
317 SUICIDE ATTEMPT 1 0.0000
318 ILL-DEFINED DISORDER 1 0.0000
319 VERTIGO 1 0.0000
320 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
321 HYPERSENSITIVITY 3 0.0000
322 BLOOD CREATININE INCREASED 1 0.0000
323 DEHYDRATION 2 0.0000
324 NEOPLASM MALIGNANT 1 0.0000
325 INJECTION SITE PRURITUS 1 0.0000
326 PRODUCT QUALITY ISSUE 2 0.0000
327 ERYTHEMA 3 0.0000
328 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
329 SLEEP DISORDER 1 0.0000
330 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
331 CONSTIPATION 3 0.0000
332 RESPIRATORY FAILURE 1 0.0000
333 OFF LABEL USE 12 0.0000
334 UNDERDOSE 1 0.0000
335 AGITATION 1 0.0000
336 BRONCHITIS 1 0.0000
337 DYSGEUSIA 1 0.0000
338 HOT FLUSH 1 0.0000
339 CHRONIC KIDNEY DISEASE 1 0.0000
340 INJECTION SITE PAIN 4 0.0000
341 DRUG INTERACTION 2 0.0000
342 CARDIAC FAILURE CONGESTIVE 1 0.0000
343 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
344 CEREBROVASCULAR ACCIDENT 2 0.0000
345 RASH 5 0.0000
346 PRODUCT STORAGE ERROR 1 0.0000
347 INTENTIONAL PRODUCT MISUSE 1 0.0000
348 MUSCULOSKELETAL STIFFNESS 1 0.0000
349 INSOMNIA 3 0.0000
350 OROPHARYNGEAL PAIN 1 0.0000
351 BREAST CANCER 1 0.0000
352 COUGH 3 0.0000
353 DYSPNOEA 6 0.0000
354 NEUROPATHY PERIPHERAL 1 0.0000
355 CONTUSION 1 0.0000
356 ALOPECIA 2 0.0000
357 HEART RATE INCREASED 1 0.0000
358 HYPOTENSION 2 0.0000
359 SOMNOLENCE 2 0.0000
360 CONDITION AGGRAVATED 3 0.0000
361 FLUSHING 1 0.0000
362 PAIN 6 0.0000
363 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
364 ABDOMINAL PAIN UPPER 2 0.0000
365 ILLNESS 1 0.0000
366 PNEUMONIA 3 0.0000
367 WEIGHT INCREASED 2 0.0000
368 DEPRESSION 2 0.0000
369 ABDOMINAL PAIN 2 0.0000
370 CHILLS 1 0.0000
371 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
372 HYPERHIDROSIS 1 0.0000
373 DRY SKIN 1 0.0000
374 VISION BLURRED 1 0.0000
375 DRUG INEFFECTIVE 9 0.0000
376 ABDOMINAL DISCOMFORT 1 0.0000
377 COVID-19 1 0.0000
378 NO ADVERSE EVENT 1 0.0000
379 CHEST PAIN 1 0.0000
380 ANAEMIA 1 0.0000
381 OVERDOSE 1 0.0000